The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis

Title
The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
Authors
Keywords
recurrent or metastatic nasopharyngeal carcinoma, PD-1, PD-L1, Response rate, Survival rate, Adverse events
Journal
ORAL ONCOLOGY
Volume 104, Issue -, Pages 104640
Publisher
Elsevier BV
Online
2020-03-15
DOI
10.1016/j.oraloncology.2020.104640

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started